Clinician's Roundtable

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Brennan Spiegel, MD, MSHS With colorectal cancer screening rates still lagging, blood-based liquid biopsy tests are emerging as a promising strategy to improve adherence, especially among those reluctant to undergo traditional screening methods. However, these tests come with some challenges that may limit their real-world effectiveness. Joining Dr. Charles Turck to discuss these potential benefits and barriers is Dr. Brennan Spiegel, a Professor of Medicine in Public Health and the Director of Health Services Research at Cedar-Sinai in Los Angeles.